Investment Thesis
Synopsys demonstrates strong revenue growth (+15.1% YoY) and exceptional cash generation (34.1% FCF margin), with a fortress balance sheet and healthy liquidity position. However, profitability metrics are concerning with collapsing net income (-0.1% YoY), diluted EPS down 44.6% YoY, and net margin compressed to 2.7% despite strong gross margins, suggesting operational challenges that require monitoring.
Strengths
- Strong revenue growth of 15.1% YoY demonstrates market demand and business expansion
- Exceptional free cash flow generation at $821.5M with 34.1% FCF margin indicates efficient core operations
- Fortress balance sheet with $30.5B equity, 0.33x debt-to-equity ratio, and 153.4x interest coverage providing financial flexibility
- High gross margin of 73.5% reflects strong pricing power and product differentiation
- Solid liquidity with 1.36x current ratio and $2.1B cash position
Risks
- Net income essentially flat YoY despite 15.1% revenue growth, indicating margin compression and operational inefficiency
- Diluted EPS collapsed 44.6% YoY, signaling significant shareholder value destruction from increased shares or non-operating charges
- Operating margin of 8.4% is thin relative to gross margin of 73.5%, suggesting high operating expenses consuming most gross profit
- Net margin of only 2.7% leaves minimal buffer for any adverse business developments or economic headwinds
- Return on equity (0.2%) and ROA (0.1%) are extremely poor relative to equity and asset base, indicating poor capital deployment efficiency
Key Metrics to Watch
- Operating margin trend - need to see expansion above 8.4% to justify premium valuation
- Net income growth reconciliation - critical to understand whether profit decline is operational or non-recurring
- Free cash flow sustainability - monitor if 34.1% FCF margin can be maintained as revenue growth moderates
- Operating expense ratio - track whether SG&A and R&D spending normalize or remain elevated
- Return on invested capital - improve ROIC metrics to demonstrate effective use of $30.5B equity base
Financial Metrics
Revenue
2.4B
Net Income
65.0M
EPS (Diluted)
$0.34
Free Cash Flow
821.5M
Total Assets
47.2B
Cash
2.1B
Profitability Ratios
Gross Margin
73.5%
Operating Margin
8.4%
Net Margin
2.7%
ROE
0.2%
ROA
0.1%
FCF Margin
34.1%
Balance Sheet & Liquidity
Current Ratio
1.36x
Quick Ratio
1.26x
Debt/Equity
0.33x
Debt/Assets
35.3%
Interest Coverage
153.36x
Long-term Debt
10.0B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-19T19:45:04.240238 |
Data as of: 2026-01-31 |
Powered by Claude AI